“…Various parameters, which were included in the ADMET studies, are LogS, logS @ pH7.4, LogP, LogD, 2C9 pKi, hERG pIC50, BBB log ([brain]:[blood]), BBB category, HIA category, P-gp category, 2D6 affinity category, PPB90 category as pharmacokinetic features and Mitochondrial dysfunction, Thyroid toxicity, Photoallergenicity, Skin sensitization, Occupational asthma, Respiratory sensitization, Developmental toxicity, Teratogenicity, Bradycardia, Adrenal gland toxicity, Blood in urine, Mutagenicity in vitro , Mutagenicity in vivo , Photomutagenicity in vitro , alpha-2-mu-Globulin nephropathy, Anaphylaxis, Bladder urothelial hyperplasia, Cardiotoxicity, Cerebral oedema, Chloracne, Cholinesterase inhibition, Cumulative effect on white cell count and immunology, Cyanide-type effects, High acute toxicity, Methaemoglobinaemia, Nephrotoxicity, Neurotoxicity, Oestrogenicity, Peroxisome proliferation, Phospholipidosis, Phototoxicity, Kidney disorders, Bone marrow toxicity, Splenotoxicity, Irritation (of the gastrointestinal tract), Irritation (of the respiratory tract), Irritation (of the skin), Lachrymation, HERG channel inhibition in vitro , Hepato- toxicity, Non specific genotoxicity in vitro , Non specific genotoxicity in vivo , Photo-induced non-specific geno- toxicity in vitro , Photo-induced non-specific genotoxicity in vivo , Chromosome damage in vitro , Chromosome damage in vivo , Photo-induced chromosome damage in vitro , Carcino- genicity, Photocarcinogenicity, Pulmonary toxicity, Uncoupler of oxidative phosphorylation, Irritation (of the eye), Testicular toxicity, Ocular toxicity, Kidney function-related toxicity, Bladder disorders and Urolithiasis as toxicological features [ 38 - 40 ]. Results are presented in Table 2 .…”